Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Bayarri Lara, Clara ^a   Ortega, Francisco G ^b   Cueto Ladrón De Guevara, Antonio ^a   Puche, Jose L ^b,c   Ruiz Zafra, Javier ^a   De Miguel Pérez, Diego ^b   Ramos, Abel Sánchez Palencia ^a   Giraldo Ospina, Carlos Fernando ^a   Navajas Gómez, Juan A ^a   Delgado Rodriguez, Miguel ^d   Lorente, Jose A ^b,e   Serrano, María Jose ^b,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b PTS Granada   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d UNIVERSITY OF JAÉN   (Spain)

^e UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR PROTEIN, HUMAN; KERATIN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL COUNT; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PHENOTYPE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RADICAL RESECTION; RISK ASSESSMENT; ADULT; CARCINOMA, NON-SMALL-CELL LUNG; COHORT ANALYSIS; DIAGNOSIS; LONGITUDINAL STUDY; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SECONDARY; TUMOR EMBOLISM; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; KERATINS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84979077010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148659     Document Type: Article

References (21)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. CA Cancer J Clin. 2014; 64(1): 9-29. doi: 10.3322/caac.21208 PMID: 24399786
2. Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D'Amico TA, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009; 115(22): 5218-27. doi: 10.1002/cncr.24625 PMID: 19672942
3. Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, et al. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014; 45(2): 262-7. doi: 10.1093/ejcts/ezt333 PMID: 23811122
4. O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, et al. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer. 2012; 76(1): 19-25. doi: 10.1016/j.lungcan.2011.10.018 PMID: 22209049
5. Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J Clin Oncol. 2011; 29(12): 1547-55. doi: 10.1200/JCO.2010.30.5151 PMID: 21422427
6. Serrano MJ, Nadal R, Lorente JA, Salido M, Rodríguez R, Rodríguez M, et al. Circulating cancer cells in division in an early breast cancer patient. Ann Oncol. 2011; 22(9): 2150-1. doi: 10.1093/annonc/mdr322 PMID: 21743104
7. Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL. Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res. 2012; 14(3): R71. PMID: 22554015
8. Serrano MJ, Sánchez-Rovira P, Delgado-Rodriguez M, Gaforio JJ. Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer. Cancer Biol Ther. 2009; 8(8): 671-5. PMID: 19242121
9. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011; 29(12): 1556-63. doi: 10.1200/JCO.2010.28.7045 PMID: 21422424
10. Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Fléjou JF, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res. 2011; 17(4): 827-35. doi: 10.1158/1078-0432.CCR-10-0445 PMID: 21098695
11. Rolle A, Günzel R, Pachmann U, Willen B, Höffken K, Pachmann K. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report. World J Surg Oncol. 2005; 3(1): 18. PMID: 15801980
12. Okumura Y, Tanaka F, Yoneda K, Hashimoto M, Takuwa T, Kondo N, et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg. 2009; 87(6): 1669-75. doi: 10.1016/j.athoracsur.2009.03.073 PMID: 19463575
13. Sawabata N, Okumura M, Utsumi T, Inoue M, Shiono H, Minami M, et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg. 2007; 55(5): 189-92. PMID: 17554991
14. Hofman V, Ilie M, Long E, Guibert N, Selva E, Washetine K, et al. Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls. Curr Mol Med. 2014; 14(4): 440-56. PMID: 24730524
15. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med. 2008; 359(4): 366-77. doi: 10.1056/NEJMoa0800668 PMID: 18596266
16. Sundaresan TK, Sequist LV, Heymach JV, Riely GJ, Janne PA, Koch WH, et al. Detection of T790M, the acquired resistance EGFR mutation, by tumor biopsy versus noninvasive blood-based analyses. Clin Cancer Res. 2015; In press.
17. Traynor AM, Weigel TL, Oettel KR. Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer. Lung Cancer. 2013; 81(1): 138-41. doi: 10.1016/j.lungcan.2013.03.020 PMID: 23628526
18. Han W, Lo H-W. Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations. Cancer Lett. 2012; 318: 124-134. doi: 10.1016/j.canlet.2012.01.011 PMID: 22261334
19. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993; 138(11): 923-36. PMID: 8256780
20. Nadal R, Ortega FG, Salido M, Lorente JA, Rodríguez-Rivera M, Delgado-Rodríguez M, et al. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer. 2013; 133(10): 2398-407. doi: 10.1002/ijc.28263 PMID: 23661576
21. Serrano MJ, Ortega FG, Alvarez-Cubero MJ, Nadal R, Sanchez-Rovira P, Salido M, et al. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer. Oncotarget. 2014; 5(17): 7486-97. PMID: 25277187